SiRNAs: Potential therapeutic agents against Hepatitis C Virus

Virology Journal

Volumn 8, Issue , 2011, Pages

  Ashfaq, Usman A ^a   Yousaf, Muhammad Z ^b   Aslam, Maida ^a   Ejaz, Rahat ^a   Jahan, Shah ^a   Ullah, Obaid ^b  

^a UNIVERSITY OF THE PUNJAB   (Pakistan)

^b UNIVERSITY OF VETERINARY AND ANIMAL SCIENCES   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; APOLIPOPROTEIN B; APOLIPOPROTEIN E; CD81 ANTIGEN; CLAUDIN 1; COMPLEMENTARY RNA; FAS ANTIGEN; FAS LIGAND; INTERFERON; LAMIN A; LAMIN C; OCCLUDIN; POLYPYRIMIDINE TRACT BINDING PROTEIN; RNA; SCAVENGER RECEPTOR BI; SMALL INTERFERING RNA; SYNAPTOBREVIN; VIRUS RNA; ANTIVIRUS AGENT; BIOLOGICAL PRODUCT;

ANTIVIRAL THERAPY; CELL CULTURE; DRUG TARGETING; GENE SILENCING; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IN VITRO STUDY; LIVER CELL CARCINOMA; NONHUMAN; PROTEIN EXPRESSION; PROTEIN INTERACTION; REVIEW; RNA INTERFERENCE; VIRUS GENE; VIRUS REPLICATION; DRUG EFFECT; GENETICS; VIROLOGY;

HEPATITIS C VIRUS;

ANTIVIRAL AGENTS; BIOLOGICAL PRODUCTS; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; RNA, SMALL INTERFERING;

EID: 79957922551     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-8-276     Document Type: Review

References (63)

1. Epidemiology of hepatitis C virus infection in Pakistan. J Microbiol Immunol Infect. NS Raja KA Janjua, J Microbiol Immunol Infect 2008 41 4 8 18327420 (Pubitemid 351792115)
2. Hepatitis C and liver transplantation. M Berenguer FX Lopez-Labrador TL Wright, J Hepatol 2001 35 666 678 10.1016/S0168-8278(01)00179-9 11690716 (Pubitemid 33078280)
3. World Health Organization. Department of Measurement and Health Information. WHO, 2004 http://www.who.int/healthinfo/statistics/ bodgbddeathdalyestimates.xls
4. RNA interference blocks gene expression and RNA synthesis from hepatitis C replicons propagated in human liver cells. JA Wilson S Jayasena A Khvorova S Sabatinos IG Rodrigue-Gervais S Arya F Sarangi M Harris-Brandts S Beaulieu CD Richardson, Proc Natl Acad Sci USA 2003 100 2783 2788 10.1073/pnas.252758799 12594341 (Pubitemid 36297576)
5. Approaching a new era for hepatitis C virus therapy: inhibitors of the NS3-4A serine protease and the NS5B RNA-dependent RNA polymerase. R De Francesco L Tomei S Altamura V Summa G Migliaccio, Antiviral Res 2003 58 1 16 10.1016/S0166-3542(03)00028-7 12719002 (Pubitemid 36507217)
6. Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey. F McOmish PL Yap BC Dow, J Clin Microbiol 1994 32 884 892 7913097 (Pubitemid 24100056)
7. Hepatitis C virus type 1b (II) infection in France and Italy. JB Nousbaum S Pol B Nalpas Group atCS, Ann Intern Med 1995 122 161 168 7810932
8. Frequency distribution of hepatitis C virus genotypes in different geographical regions of Pakistan and their possible routes of transmission. M Idrees S Riazuddin, BMC Infect Dis 2008 8 69 10.1186/1471-2334-8-69 18498666
9. Chronic hepatitis C virus infection. SL Flamm, Jama 2003 289 2413 2417 10.1001/jama.289.18.2413 12746366 (Pubitemid 37430175)
10. Treatment of chronic hepatitis C with PEGylated interferon and ribavirin. M Cornberg H Wedemeyer MP Manns, Curr Gastroenterol Rep 2002 4 23 30 10.1007/s11894-002-0034-y 11825538
11. Ribavirin and interferon alfa-2b in chronic hepatitis C: assessment of possible pharmacokinetic and pharmacodynamic interactions. S Khakoo P Glue L Grellier B Wells A Bell C Dash I Murray-Lyon D Lypnyj B Flannery K Walters GM Dusheiko, Br J Clin Pharmacol 1998 46 563 570 9862245 (Pubitemid 28522120)
12. Cellular cofactors affecting hepatitis C virus infection and replication. G Randall M Panis JD Cooper TL Tellinghuisen KE Sukhodolets S Pfeffer M Landthaler P Landgraf S Kan BD Lindenbach,, et al. Proc Natl Acad Sci USA 2007 104 12884 12889 10.1073/pnas.0704894104 17616579 (Pubitemid 47255249)
13. RNA interference. GJ Hannon, Nature 2002 418 244 251 10.1038/418244a 12110901 (Pubitemid 34773784)
14. RNA interference - 2001. PA Sharp, Genes Dev 2001 15 485 490 10.1101/gad.880001 11238371 (Pubitemid 32205139)
15. RNA-triggered gene silencing. A Fire, Trends Genet 1999 15 358 363 10.1016/S0168-9525(99)01818-1 10461204 (Pubitemid 29417590)
16. RNA interference and its role in the regulation of eucaryotic gene expression. Z Szweykowska-Kulinska A Jarmolowski M Figlerowicz, Acta Biochim Pol 2003 50 217 229 12673363 (Pubitemid 37034244)
17. Mechanisms of gene silencing by double-stranded RNA. G Meister T Tuschl, Nature 2004 343 349 (Pubitemid 39265674)
18. RNAi-applications in parasitology. New technologies for life sciences. E Ullu C Tschudi, A Trends Guide 2000 2000 43 46
19. RNAi: gene-silencing in therapeutic intervention. DJ Shuey DE McCallus T Giordano, Drug Discov Today 2002 7 1040 1046 10.1016/S1359-6446(02)02474-1 12546893
20. RNA interference and small interfering RNAs. T Tuschl, Chembiochem 2001 2 239 245 10.1002/1439-7633(20010401)2:4<239::AID-CBIC239>3.0.CO;2-R 11828450 (Pubitemid 33722551)
21. Unlocking the potential of the human genome with RNA interference. GJ Hannon JJ Rossi, Nature 2004 431 371 378 10.1038/nature02870 15372045 (Pubitemid 39265678)
22. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. J Soutschek A Akinc B Bramlage K Charisse R Constien M Donoghue S Elbashir A Geick P Hadwiger J Harborth,, et al. Nature 2004 432 173 178 10.1038/nature03121 15538359 (Pubitemid 39545841)
23. Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs. DV Morrissey JA Lockridge L Shaw K Blanchard K Jensen W Breen K Hartsough L Machemer S Radka V Jadhav,, et al. Nat Biotechnol 2005 23 1002 1007 10.1038/nbt1122 16041363 (Pubitemid 41114035)
24. An siRNA-based microbicide protects mice from lethal herpes simplex virus 2 infection. D Palliser D Chowdhury QY Wang SJ Lee RT Bronson DM Knipe J Lieberman, Nature 2006 439 89 94 10.1038/nature04263 16306938 (Pubitemid 43053634)
25. RNAi-mediated gene silencing in non-human primates. TS Zimmermann AC Lee A Akinc B Bramlage D Bumcrot MN Fedoruk J Harborth JA Heyes LB Jeffs M John,, et al. Nature 2006 441 111 114 10.1038/nature04688 16565705
26. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. SM Elbashir J Harborth W Lendeckel A Yalcin K Weber T Tuschl, Nature 2001 411 494 498 10.1038/35078107 11373684 (Pubitemid 32494397)
27. RNA interference in adult mice. AP McCaffrey L Meuse TT Pham DS Conklin GJ Hannon MA Kay, Nature 2002 418 38 39 10.1038/418038a 12097900 (Pubitemid 34742563)
28. RNA interference is mediated by 21- and 22-nucleotide RNAs. SM Elbashir W Lendeckel T Tuschl, Genes Dev 2001 15 188 200 10.1101/gad.862301 11157775 (Pubitemid 32107664)
29. Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. NS Lee T Dohjima G Bauer H Li MJ Li A Ehsani P Salvaterra J Rossi, Nat Biotechnol 2002 20 500 505 11981565 (Pubitemid 34495938)
30. Inhibition of hepatitis B virus in mice by RNA interference. AP McCaffrey H Nakai K Pandey Z Huang FH Salazar H Xu SF Wieland PL Marion MA Kay, Nat Biotechnol 2003 21 639 644 10.1038/nbt824 12740585 (Pubitemid 36638090)
31. Inhibition of respiratory viruses by nasally administered siRNA. V Bitko A Musiyenko O Shulyayeva S Barik, Nat Med 2005 11 50 55 10.1038/nm1164 15619632 (Pubitemid 40215837)
32. A system for stable expression of short interfering RNAs in mammalian cells. TR Brummelkamp R Bernards R Agami, Science 2002 296 550 553 10.1126/science.1068999 11910072 (Pubitemid 34408678)
33. Gene therapy progress and prospects. Downregulating gene expression: the impact of RNA interference. NJ Caplen, Gene Ther 2004 11 1241 1248 10.1038/sj.gt.3302324 15292914 (Pubitemid 39173430)
34. Gene knockdown: RNA-interference is coming of age. Y Saito S Dzik, Transfusion 2005 45 111 114 10.1111/j.1537-2995.2005.04282.x 15647026
35. Interference of hepatitis C virus RNA replication by short interfering RNAs. SB Kapadia A Brideau-Andersen FV Chisari, Proc Natl Acad Sci USA 2003 100 2014 2018 10.1073/pnas.252783999 12566571 (Pubitemid 36254565)
36. Silencing of USP18 potentiates the antiviral activity of interferon against hepatitis C virus infection. G Randall L Chen M Panis AK Fischer BD Lindenbach J Sun J Heathcote CM Rice AM Edwards ID McGilvray, Gastroenterology 2006 131 1584 1591 10.1053/j.gastro.2006.08.043 17101330 (Pubitemid 44708944)
37. Suppression of hepatitis C virus replicon by RNA interference directed against the NS3 and NS5B regions of the viral genome. Y Takigawa M Nagano-Fujii L Deng R Hidajat M Tanaka H Mizuta H Hotta, Microbiol Immunol 2004 48 591 598 15322339 (Pubitemid 39100118)
38. Inhibition of intracellular hepatitis C virus replication by synthetic and vector-derived small interfering RNAs. T Yokota N Sakamoto N Enomoto Y Tanabe M Miyagishi S Maekawa L Yi M Kurosaki K Taira M Watanabe H Mizusawa, EMBO Rep 2003 4 602 608 10.1038/sj.embor.embor840 12740604 (Pubitemid 36939952)
39. Small interfering RNA-mediated inhibition of hepatitis C virus replication in the human hepatoma cell line Huh-7. MY Seo S Abrignani M Houghton JH Han, J Virol 2003 77 810 812 10.1128/JVI.77.1.810-812.2003 12477890 (Pubitemid 36005024)
40. Small interfering RNA targeted to hepatitis C virus 5' nontranslated region exerts potent antiviral effect. T Kanda R Steele R Ray RB Ray, J Virol 2007 81 669 676 10.1128/JVI.01496-06 17079316 (Pubitemid 46067893)
41. Consensus siRNA for inhibition of HCV genotype-4 replication. AR Zekri AA Bahnassy HM El-Din HM Salama, Virol J 2009 6 13 10.1186/1743-422X-6-13 19173711
42. Inhibition of HCV replication by small interfering RNA. RB Ray T Kanda, Methods Mol Biol 2009 510 251 262 10.1007/978-1-59745-394-3-19 19009267
43. Hepatitis C virus replicons escape RNA interference induced by a short interfering RNA directed against the NS5b coding region. JA Wilson CD Richardson, J Virol 2005 79 7050 7058 10.1128/JVI.79.11.7050-7058.2005 15890944 (Pubitemid 40677336)
44. RNA interference effectively inhibits mRNA accumulation and protein expression of hepatitis C virus core and E2 genes in human cells. M Liu H Ding P Zhao ZL Qin J Gao MM Cao J Luan WB Wu ZT Qi, Biosci Biotechnol Biochem 2006 70 2049 2055 10.1271/bbb.60001 16960393 (Pubitemid 44451879)
45. Inhibition of hepatitis C virus gene expression by small interfering RNAs using a tri-cistronic full-length viral replicon and a transient mouse model. M Kim D Shin SI Kim M Park, Virus Res 2006 122 1 10 10.1016/j.virusres.2006.05. 003 16979254 (Pubitemid 44634825)
46. Hairpin ribozymes in combination with siRNAs against highly conserved hepatitis C virus sequence inhibit RNA replication and protein translation from hepatitis C virus subgenomic replicons. D Jarczak M Korf C Beger MP Manns M Kruger, Febs J 2005 272 5910 5922 10.1111/j.1742-4658.2005.04986.x 16279954 (Pubitemid 41689362)
47. Small hairpin RNAs efficiently inhibit hepatitis C IRES-mediated gene expression in human tissue culture cells and a mouse model. Q Wang CH Contag H Ilves BH Johnston RL Kaspar, Mol Ther 2005 12 562 568 10.1016/j.ymthe.2005.04. 014 15953767 (Pubitemid 41150143)
48. Combined antiviral activity of interferon-alpha and RNA interference directed against hepatitis C without affecting vector delivery and gene silencing. Q Pan SD Henry HJ Metselaar B Scholte J Kwekkeboom HW Tilanus HL Janssen LJ van der Laan, J Mol Med 2009 87 713 722 10.1007/s00109-009-0470-3 19404587
49. Identification of host genes involved in hepatitis C virus replication by small interfering RNA technology. TI Ng H Mo T Pilot-Matias Y He G Koev P Krishnan R Mondal R Pithawalla W He T Dekhtyar,, et al. Hepatology 2007 45 1413 1421 10.1002/hep.21608 17518369 (Pubitemid 46918325)
50. Identification of human kinases involved in hepatitis C virus replication by small interference RNA library screening. L Supekova F Supek J Lee S Chen N Gray JP Pezacki A Schlapbach PG Schultz, J Biol Chem 2008 283 29 36 17951261
51. Roles for endocytic trafficking and phosphatidylinositol 4-kinase III alpha in hepatitis C virus replication. KL Berger JD Cooper NS Heaton R Yoon TE Oakland TX Jordan G Mateu A Grakoui G Randall, Proc Natl Acad Sci USA 2009 106 7577 7582 10.1073/pnas.0902693106 19376974
52. A functional genomic screen identifies cellular cofactors of hepatitis C virus replication. AW Tai Y Benita LF Peng SS Kim N Sakamoto RJ Xavier RT Chung, Cell Host Microbe 2009 5 298 307 10.1016/j.chom.2009.02.001 19286138
53. Identification of a lipid kinase as a host factor involved in hepatitis C virus RNA replication. FH Vaillancourt L Pilote M Cartier J Lippens M Liuzzi RC Bethell MG Cordingley G Kukolj, Virology 2009 387 5 10 10.1016/j.virol.2009.02. 039 19304308
54. Hepatitis C virus entry: molecular biology and clinical implications. H Barth TJ Liang TF Baumert, Hepatology 2006 44 527 535 10.1002/hep.21321 16941688 (Pubitemid 44433708)
55. Cell entry of hepatitis C virus. B Bartosch FL Cosset, Virology 2006 348 1 12 10.1016/j.virol.2005.12.027 16455127
56. Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. MJ Evans T von Hahn DM Tscherne AJ Syder M Panis B Wolk T Hatziioannou JA McKeating PD Bieniasz CM Rice, Nature 2007 446 801 805 10.1038/nature05654 17325668 (Pubitemid 46582027)
57. CD81 is required for hepatitis C virus glycoprotein-mediated viral infection. J Zhang G Randall A Higginbottom P Monk CM Rice JA McKeating, J Virol 2004 78 1448 1455 10.1128/JVI.78.3.1448-1455.2004 14722300 (Pubitemid 38095855)
58. Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81. MB Zeisel G Koutsoudakis EK Schnober A Haberstroh HE Blum FL Cosset T Wakita D Jaeck M Doffoel C Royer,, et al. Hepatology 2007 46 1722 1731 10.1002/hep.21994 18000990
59. RNA interference targeting Fas protects mice from fulminant hepatitis. E Song SK Lee J Wang N Ince N Ouyang J Min J Chen P Shankar J Lieberman, Nat Med 2003 9 347 351 10.1038/nm828 12579197 (Pubitemid 36362792)
60. Caspase 8 small interfering RNA prevents acute liver failure in mice. L Zender S Hutker C Liedtke HL Tillmann S Zender B Mundt M Waltemathe T Gosling P Flemming NP Malek,, et al. Proc Natl Acad Sci USA 2003 100 7797 7802 10.1073/pnas.1330920100 12810955 (Pubitemid 36760049)
61. Hsp90 inhibitors suppress HCV replication in replicon cells and humanized liver mice. S Nakagawa T Umehara C Matsuda S Kuge M Sudoh M Kohara, Biochem Biophys Res Commun 2007 353 882 888 10.1016/j.bbrc.2006.12.117 17196931 (Pubitemid 46080379)
62. Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins. H Huang F Sun DM Owen W Li Y Chen M Gale Jr J Ye, Proc Natl Acad Sci USA 2007 104 5848 5853 10.1073/pnas.0700760104 17376867 (Pubitemid 47175622)
63. Inhibition of hepatitis C virus replication and expression by small interfering RNA targeting host cellular genes. Q Xue H Ding M Liu P Zhao J Gao H Ren Y Liu ZT Qi, Arch Virol 2007 152 955 962 10.1007/s00705-006-0905-x 17273891 (Pubitemid 46664070)